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Background: Intestinal spirochetosis is an unusual infection in children and its clinical significance in humans is
uncertain. The presence of these microorganisms in humans is well-known since the late 1800’s and was first
described in 1967 by Harland and Lee by electron microscopy.
Case presentation: This article reports the findings of one pediatric case, review of the current literature, and an
overview of therapeutic options.
Conclusion: A high degree of suspicion is required in cases presenting with abdominal pain, chronic diarrhoea
and/or hematochezia associated with a normal endoscopic examination, thus emphasizing the importance of
multiple biopsies throughout the colon.
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Spirochetes are well-known pathogens in veterinary medi-
cine. They are associated with diarrheal illness, malnutri-
tion and failure to thrive in a wide range of animals
(swine, poultry, dogs, cats, opossum, non-human primates
and guinea pigs) causing important economic losses [1].
The presence of intestinal spirochetes in human faeces
has been recognized in the late 1800’s [2]. The term in-
testinal spirochetosis was coined in 1967 by Harland and
Lee who recognized spirochetes adherent to the cellular
membrane of apical cells in the colonic epithelium [3].
This histological appearance is considered to be the hall-
mark of this infection.
The clinical significance of intestinal spirochetes in
humans remains highly debated. Indeed, it is still unclear
whether the finding of microorganisms coating the intestinal
mucosal membrane is simply the reflection of a colonization
process or the histological aspect of a disease [4].Case presentation
A 13 year-old boy presented to our paediatric gastro-
enterology outpatient clinic with a one month history of* Correspondence: Andreas.Nydegger@chuv.ch
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reproduction in any medium, provided the orblood-stained diarrhoea, associated with urgency, weight
loss of 1.5kg and asthenia. He had no complaint of ab-
dominal pain, fever or anorexia. The onset of symptoms
coincided with the end of a 4-day history of acute
gastroenteritis.
His past medical history revealed a recurrent aphthous
stomatitis, and his family history was positive for celiac
disease (one maternal cousin), irritable bowel syndrome
(one paternal uncle) and bowel cancer (paternal grand-
father). His growth parameters were normal and the
physical examination revealed palpable stool masses in
the left lower abdomen. Based on the clinical presenta-
tion, the differential diagnosis included inflammatory
bowel disease, celiac disease, infectious colitis and intes-
tinal polyp. Laboratory investigations showed no bio-
logical markers for inflammation (normal full blood
count, ESR: 5mm/h and CRP: 0.28mg/l) or celiac dis-
ease. Fecal calprotectin was not measured. Stool cultures
for conventional enteric pathogens (Salmonella, Shigella
Campylobacter) were negative. Upper and lower endos-
copy revealed mucosal oedema in the sigmoid and rectum,
which was probably due to the required bowel preparation
for colonoscopy. Histological examination on conven-
tional hematoxylin and eosin stain of the colonic biopsy
specimens revealed a fuzzy band on the surface of the
enterocytes. This finding was highly suggestive of intes-
tinal spirochetosis (Figure 1). Interestingly, no specificl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 A: Hematoxylin and eosin stain of colon biopsy
specimen showing multitudes of organisms along apical border
of enterocytes, resembling a “false brush border” (H&E, orig.
mag. x10). B: Colonic mucosa with thick hematoxyphilic fringe on
the brush border of the luminal surface (H&E, orig. mag. X40).
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nosis of intestinal spirochetosis was confirmed by Fluores-
cence in situ hybridization (FISH), confirming the
presence of Brachyspira aalborgi (Figure 2).
On the assumption that most intestinal spirochetes
(obtained from veterinary specimens) are susceptible to
amoxicillin, the patient was initially treated with this
antibiotic (30mg/kg/day, divided into 3 doses) during 14
days, with subsequent cessation of rectal bleeding but
persistent mucous diarrhoea. Additional treatment with
metronidazole (30mg/kg/day, divided into 3 doses) for
10 days resulted in complete resolution of symptoms,
therefore, no follow-up endoscopy was performed.Figure 2 Visualisation and identification of Brachyspira spp. in
a colon biopsy specimen by FISH (white arrows). Blue dots stand
for counterstained cell nuclei.Methods
A Medline search was performed for all studies pub-
lished from 1993 to December 2011 using the Medical
Subject Heading and keywords: “intestinal spirochetosis”
and “all child (0–18 years)”. Articles in any otherlanguage than English have been excluded. All studies
retrieved were considered and data from relevant’ ones
were presented in Table 1 and discussed in the text.
Results
To the best of our knowledge, there were 8 articles de-
scribing a total of 25 paediatric cases of intestinal spiro-
chetosis [5-12]. Three patients presented spirochetes on
histopathological examination of a resected appendix
without endoscopy. Sex distribution was similar (13 girls,
12 boys) with a median age of 9.5 years (range: 2–17
years). Patients mainly presented with abdominal pain,
diarrhoea and rectal bleeding with, apart from aspecific
signs of mild inflammation, normal endoscopic findings.
Table 1 summarizes those 25 patients with respect to their
age, symptoms, endoscopic and histological findings and
treatment. Many patients had more than one treatment
due to persistence of symptoms, although metronidazole
seemed to be the favourite therapeutic agent. Two out of
5 patients improved without treatment and the overall
outcome was favourable in 17 patients (68%).
Discussion
Adhesion of spirochetes to the brush border mucosa
resulting in its thickening as seen on light microscopy
can be observed worldwide in both children and adults
[1]. Diagnosis is usually made by histopathology.
Spirochetes are currently divided into three phylogen-
etic groups: Spirochaetaceae including Borrelia, Spiro-
chaeta, Spironema and Treponema; Leptospiraceae
including Leptonema and Leptospira; and finally Brachy-
spiraceae containing the intestinal spirochetes of Brachy-
spira (Serpulina) [1]. Brachyspira aalborgi (B. aalborgi)
and Brachyspira pilosicoli (B. pilosicoli), the two mem-
bers of Brachyspiraceae family, are both described in
Table 1 Description of 25 cases of pediatric intestinal spirochetosis (IS)
Ref. Age (y) Sex Signs and
Symptoms
Endoscopic
findings
Histologic
findings
Treatment Comments
[5] 6 F Rectal bleeding,
abdominal pain,
pruritus ani
Normal IS and mild
inflammation
Piperazine Improvement
2 M Intermittent
bloody diarrhoea
Distal colitis IS and mild to
moderate infiltration
with inflammatory cells
Mebendazole
(Ascaris in stool)
Improvement
13 M Recurrent fever,
abdominal pain,
joint pain, mouth
and penile ulcers
Normal IS and mild patchy
inflammation
No treatment No follow-up
information
[6] 7.5 M Periumbilical pain,
frequent bloody stools,
urgency, poor appetite
and weight loss
Mild rectal
granularity
IS 1) Metronidazole Persistence of
diarrhea;
eradication on
endoscopic
follow-up at
6 months
2) Neomycine
8 F Acute abdominal pain,
vomiting and fever
Not done IS in resected
appendix
No treatment Improvement
[7] 12 M Intermittent vomiting,
diarrhoea, weight loss,
headaches and fatigue
Normal IS and mild
focal colitis
Metronidazole and
Amoxicillin (7 days)
Improvement
12 M Recurrent
abdominal
pain
Normal IS and mild focal
cryptitis in the
caecum
1) Penicillin V and
Metronidazole (7 days)
Persistence of
symptoms and IS;
after second course
of Metronidazole
eradication and
improvement
2) Metrodidazole
(800mg 3x/d for 7 days)
16 F Recurrent colicky
right upper quadrant
pain
Normal IS Metronidazole and
Amoxicillin (10 days)
Improvement
9 F Intermittent diarrhoea
and rectal bleeding
Normal IS Metronidazole and
Amoxicillin (10 days)
Improvement
[8] 5 F Abdominal pain,
diarrhoea and rectal
bleeding
Rectal oedema
and enterobiasis
IS Erythromycin
(40mg/kg/d for 10 days)
Rectal bleeding
ceased but abdominal
pain recurred,
no follow-up
7 M Abdominal pain
and diarrhoea
Slight proctitis IS Doxycycline (200mg day1,
then 100mg/d for 8 days )
Persistence of
abdominal pain
despite endoscopic
eradication
4 F Mucus and bloody
stools
Proctitis,
juvenile polyp
IS Clarithromycin
(50mg/kg/d for
10 days)
Improvement
10 F Diarrhoea and
rectal bleeding
Rectal hyperaemic
membranes
IS Clarithromycin Improvement
13 M Abdominal pain,
nausea and weight
loss
Slight
inflammation
of rectum
IS and HP- positive
gastritis
1) Clarithromycin and
Amoxicillin
Persistence of IS,
eradication after
Clarithromycin
and Metronidazole2) Clarithromycin and
Metronidazole (500mg 2x/d
and 400mg 3x/d 7 days)
8 M Recurrent
abdominal
pain
Juvenile polyp IS and low-grade
chronic
inflammation
1) Penicillin V Improvement after
Erythromycin
2) Erythromycin (40-50mg/kg/d
for 10 days)
15 F Abdominal pain and
rectal bleeding
Normal IS Clarithromycin (500mg 2x/d
for 14 days)
Improvement but
persistence of
rectal bleeding;
absence of IS on
follow-up rectoscopy
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Table 1 Description of 25 cases of pediatric intestinal spirochetosis (IS) (Continued)
14 F Abdominal pain Normal IS Metronidazole (400mg 3x/d
for 10 days)
No improvement;
absence of IS on
follow-up
colonoscopy
[9] 9 M Recurrent abdominal
pain, diarrhea and
rectal bleeding
Mild erythema
of rectal mucosa
IS and
hypereosinophilia
Erythromycin (40mg/kg/d
for 10 days)
Improvement
[10] 9 M Rectal bleeding,
diarrhea, tenesmus,
flatulence and weight
loss
Normal IS and mild epithelial
reactive changes
No treatment Improvement
[11] 4 F Abdominal discomfort,
rectal bleeding and
weight loss
Mucosal erosions,
hyperemia, 2
juvenile
polyps
IS and inflammatory
infiltrate
Metronidazole Improvement
[12] 11 F Intermittent
abdominal
pain and rectal
bleeding
Normal IS 1)Metronidazole
(250mg 3x/d)
No improvement,
additional course
of Metronidazole and
Vancomycin with
persistence of IS,
no follow-up
information
2) Metronidazole (1000mg/d
for 2 months and 750 mg/d
for 14 days)
3) Vancomycin (7 days)
6 M Stomach cramps,
rectal bleeding,
intermittent diarrhea,
rectal prolapse
Normal IS Metronidazole
(250mg 2x/d)
Improvement,
but alternating
constipation with
watery diarrhea and
rectal prolapse
17 F Recurrent
abdominal pain,
nausea, vomiting
Normal IS and mild eosinophilic
inflammatory infiltrate
No treatment No follow-up
information
11 F Right lower
quadrant pain
Not done Appendicitis and IS in
resected appendix
Cefoxitin (30mg/kg/dose,
4 doses)
No follow-up
information
10 M Periumbilical and
epigastric pain,
nausea, fever
Not done Appendicitis and IS in
resected appendix
No treatment No follow-up
information
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intestinal spirochetosis [13]. The anaerobic weakly β-
haemolytic intestinal spirochete B. aalborgi, was first
isolated in 1982 in the stool of a patient from Denmark
[14], whereas B. pilosicoli is responsible for colitis and
typhlytis in pigs, poultry and other species, acting more
as zoonotic agent [15]. Since 1997, Brachyspira spp. have
been included in the list of human enteropathogenic
bacteria [16]. These two spirochetes are slow growing
fastidious anaerobes and require specific media, with
estimated growth times of 6 days for B. pilosicoli and up
to 2 weeks for B.aalborgi [17]. Morphologically, they are
coiled Gram-negative bacilli and are mobile in liquid en-
vironment due to the presence of flagella. Generally they
are considered non invasive microorganisms but sys-
temic spread of B.pilosicoli has been documented by cul-
ture of blood specimens obtained from critically ill
patients [18]. Concomitant infection by B.aalborgi and
B.pilosicoli is described but rare [19]. These spirochetes
are susceptible to different antibiotics, such as metro-
nidazole, meropenem, chloramphenicol, ceftriaxone andtetracycline, whereas a 60% resistance rate to ciprofloxa-
cine has been observed [20]. Little is known about the
way of transmission, but it seems likely to occur by
faecal-oral route (contaminated water, colonized/infected
faeces) [19]. Due to the higher prevalence in homosexual
men, sexual transmission has been suggested as well
[21]. Possible co-infection with others microorganisms
like Helicobacter pylori, Enterobius vermicularis, Shigella
flexneri, Neisseria gonorrhoeae, Entamoeba histolytica,
Blastocystis hominis, and Ascaris is possible, rendering
clinical significance difficult [2].
The prevalence varies considerably in geography and
immune condition. In developed countries for example
ranges between 1.1-5% can be observed, with an increase
in homosexual men and HIV positive patients [1]. In a
recent study from Japan the incidence of human intes-
tinal spirochetosis in patients aged from 35 to 75 years
was 0.4% and therefore lower than in Western countries
[22]. The paucity of epidemiologic data is probably due
to several reasons: firstly: the endoscopist not always
takes routine multiple biopsies in healthy looking
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for spirochetes and can easily miss them if not familiar
with its appearance and thirdly: it is not a routine diag-
nosis by microbiologist either [11].
In most cases, intestinal spirochetosis is asymptomatic
and presents as accidental findings during a screening
colonoscopy for other reasons [23]. However, infected
children usually complain of persistent diarrhoea, rectal
bleeding, constipation, abdominal pain, weight loss, fail-
ure to thrive, nausea and lack of appetite [24]. The sever-
ity of disease can vary from asymptomatic colonisation to
invasive and rapidly fatal progression [25], but there
appears to be no correlation with degree of immunodefi-
ciency in HIV positive patient and the extent of disease
[1]. Due to this unspecific presentation, differential
diagnosis should include inflammatory bowel disease,
infectious, ischemic or pseudomembranous colitis and
rectocolic carcinoma [24]. Colonic involvement is docu-
mented from distal to proximal, including rectum and ap-
pendix [26]. Mucosal appearance on endoscopy is not
helpful in making the diagnosis, as it can be normal,
polypoid, and erythematous, or just show unspecific
lesions [27]. In a large Australian case series of 113 adult
patients presenting with intestinal spirochetosis, 90 per-
cent of colorectal specimens showed no morphological
alterations, whereas the remaining cases had other
possible causes for inflammation [23]. Histological
appearance of a diffuse blue-fringe (better seen in
hematoxylin-eosin or a silver stain), 3-6μm thick, along
the border of intestinal epithelial layer, referred to as the «
false brush border » is highly suggestive [1]. The sur-
rounding cytostructure may show inflammation with
slight oedema, infiltrate of monocytes, lymphocytes,
plasma cells and neutrophils in the lamina propria, as well
as elongated and hyperplastic crypts [28]. On electron mi-
croscopy, spirochetes are attached perpendicularly to the
epithelial membrane of the enterocytes and the microvilli
appear shortened or depleted [3]. Analysis of specimens
from infected individuals even though rare has shown
spirochetal invasion of colonic epithelial cells, macro-
phages, goblet cells and Schwann cells [29]. Histologically
it is not possible to distinguish B.pilosicoli from B.aalborgi,
therefore genetic methods have been developed in order
to identify Brachyspira species from stool or tissue sam-
ples. Fluorescent in situ hybridization using oligonucleo-
tide probes targeting 16S or 23S rRNA of B. aalborgi and
B. pilosicoli allow visualisation and identification of this
microorganism [28].
Treatment strategies have been proposed for intestinal
spirochetosis eradication, including macrolids and clin-
damycin, but metronidazole seems to be the drug of
choice, with a dose regimen of 500mg 3 times a day for
10 days in adults and 15mg per kg bodyweight 3 times
per day for 5 days in children [19]. At the moment, thereis lack of evidence regarding the most effective antibiotic
agent as treatment response is variable and sometimes
even ineffective supporting the hypothesis that these
microorganisms are harmless commensals in humans,
rendering specific treatment questionable [1]. Spontan-
eous recovery has been described after a prolonged
period for up to 8 months [8].Conclusions
Intestinal spirochetosis may be more frequent than sus-
pected and clinicians should take into account this dis-
ease, especially in case of persistent diarrhoea without
any other reason. Diagnosis can only be made by an
experienced pathologist and microbiologist and requires
a lower endoscopy with multiple biopsies throughout
the colon.
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